Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vitamin D During Pregnancy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01589783
First received: April 1, 2012
Last updated: July 26, 2015
Last verified: July 2015
  Purpose
Vitamin D insufficiency is common globally. Pregnant women, who need an increased supply of this vitamin for the proper development of the fetus, are a significant risk group. The purpose of this study is to examine which factors - education, knowledge from non-professional sources, recommendations from medical staff - influence the use of vitamin D among pregnant women in light of the lack of a clear health policy, and to help formulating guidelines for a new health policy with specific recommendations for vitamin D dosage in pregnancy.

Condition Intervention
Vitamin D Deficiency
Other: completion of a questionnaire
Other: Blood draw

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Evaluation of the Influence of Education, Knowledge and Existing Guidelines on the Consumption of Vitamin D During Pregnancy.

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • Use of Vitamin D in Pregnant Women [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Enrollment: 764
Study Start Date: May 2012
Study Completion Date: June 2015
Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Pregnant or newly post partum women Other: completion of a questionnaire
Completion of a questionnaire
Other: Blood draw
A subset of 100 women will have a blood test to measure Vitamin D levels
family practice physicians and obstetricians Other: completion of a questionnaire
Completion of a questionnaire

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
We are recruiting either pregnant women or those who just gave birth (and still hospitalized) and a group of both family practice physicians and obstertricians.
Criteria

Inclusion Criteria for the pregnant of newly post-partum women:

  • women between 18-50
  • pregnant or just given birth and still hospitalized
  • understand and can read Hebrew

Exclusion Criteria:

  • those who do not understand or read Hebrew
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01589783

Locations
Israel
Hadassah Medical Organization
Jerusalem, Israel
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Drorith Hochner, MD Hadassah Medical Organization
  More Information

Responsible Party: Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01589783     History of Changes
Other Study ID Numbers: VitDand Preg-HMO-CTIL 
Study First Received: April 1, 2012
Last Updated: July 26, 2015
Health Authority: Israel: Ministry of Health

Keywords provided by Hadassah Medical Organization:
Pregnancy
Vitamin D

Additional relevant MeSH terms:
Vitamin D Deficiency
Avitaminosis
Deficiency Diseases
Malnutrition
Nutrition Disorders
Vitamins
Vitamin D
Ergocalciferols
Micronutrients
Growth Substances
Physiological Effects of Drugs
Bone Density Conservation Agents

ClinicalTrials.gov processed this record on September 28, 2016